TickerFacts.

A business in context

BCDA research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-10-19 · 0001437749-26-032887 · Items 8.01,9.01

  2. 8-K · Current report

    Report date 2026-10-07 · 0001437749-26-032270 · Items 8.01,9.01

  3. 8-K · Current report

    Report date 2026-10-01 · 0001437749-26-031665 · Items 8.01,9.01

  4. 4 · Ownership change

    Report date 2026-09-29 · 0001437749-26-031638

  5. 4 · Ownership change

    Report date 2026-09-23 · 0001437749-26-031093

  6. 8-K · Current report

    Report date 2026-09-23 · 0001437749-26-031011 · Items 8.01,9.01

  7. 8-K · Current report

    Report date 2026-09-21 · 0001437749-26-030831 · Items 8.01

  8. 8-K · Current report

    Report date 2026-09-10 · 0001437749-26-030023 · Items 8.01,9.01

  9. 4 · Ownership change

    Report date 2026-09-03 · 0001437749-26-029732

  10. 8-K · Current report

    Report date 2026-08-24 · 0001437749-26-028778 · Items 7.01,9.01

  11. 8-K · Current report

    Report date 2026-08-19 · 0001437749-26-028744 · Items 3.01

  12. 4 · Ownership change

    Report date 2026-08-17 · 0001437749-26-028307

  13. 4 · Ownership change

    Report date 2026-08-13 · 0001437749-26-027743

  14. 8-K · Current report

    Report date 2026-08-12 · 0001437749-26-027332 · Items 2.02,9.01

  15. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001437749-26-027315

  16. 4 · Ownership change

    Report date 2026-07-29 · 0001437749-26-024925

  17. 4 · Ownership change

    Report date 2026-07-17 · 0001437749-26-023868

  18. 4 · Ownership change

    Report date 2026-07-14 · 0001437749-26-023637

  19. 8-K · Current report

    Report date 2026-06-18 · 0001437749-26-021041 · Items 7.01,9.01

  20. 8-K · Current report

    Report date 2026-06-12 · 0001437749-26-020384 · Items 3.01

  21. 8-K · Current report

    Report date 2026-06-08 · 0001437749-26-019789 · Items 8.01,9.01

  22. 8-K · Current report

    Report date 2026-06-05 · 0001437749-26-019653 · Items 7.01,9.01

  23. 8-K · Current report

    Report date 2026-05-28 · 0001437749-26-018670 · Items 7.01,9.01

  24. 8-K · Current report

    Report date 2026-05-21 · 0001437749-26-017994 · Items 7.01,9.01

  25. 8-K · Current report

    Report date 2026-05-15 · 0001437749-26-017222 · Items 2.02,9.01

  26. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001437749-26-017221

  27. 8-K · Current report

    Report date 2026-05-08 · 0001437749-26-015753 · Items 7.01,9.01

  28. 8-K · Current report

    Report date 2026-04-28 · 0001437749-26-013535 · Items 8.01,9.01

  29. 8-K · Current report

    Report date 2026-04-20 · 0001437749-26-012764 · Items 7.01,9.01

  30. 8-K · Current report

    Report date 2026-04-10 · 0001437749-26-012412 · Items 3.01

  31. 8-K · Current report

    Report date 2026-04-02 · 0001437749-26-010967 · Items 7.01,9.01

  32. 8-K · Current report

    Report date 2026-03-24 · 0001437749-26-009609 · Items 2.02,9.01

  33. 10-K · Annual report

    Report date 2025-12-31 · 0001437749-26-009587

  34. 8-K · Current report

    Report date 2026-03-17 · 0001437749-26-008499 · Items 8.01,9.01

  35. 8-K · Current report

    Report date 2026-03-03 · 0001437749-26-006481 · Items 7.01,9.01

  36. 8-K · Current report

    Report date 2026-02-10 · 0001437749-26-003582 · Items 8.01,9.01

  37. 8-K · Current report

    Report date 2026-02-03 · 0001437749-26-002723 · Items 8.01,9.01

  38. 8-K · Current report

    Report date 2025-12-16 · 0001437749-25-037910 · Items 7.01,9.01

  39. 8-K · Current report

    Report date 2025-12-02 · 0001437749-25-036711 · Items 5.02,5.07,7.01,9.01

  40. 8-K · Current report

    Report date 2025-11-24 · 0001437749-25-036076 · Items 8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 13 transaction rows13PSale: 0 transaction rows0SGrant / award: 12 transaction rows12AExercise / conversion: 0 transaction rows0MTax / exercise payment: 3 transaction rows3FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

28 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-29
2026-09-30
Altman PeterP · Purchase
Acquired
Common Stock1000.01.03
2026-09-23
2026-09-23
Altman PeterP · Purchase
Acquired
Common Stock1900.01.05
2026-09-03
2026-09-04
Altman PeterP · Purchase
Acquired
Common Stock800.01.09
2026-08-17
2026-08-18
Altman PeterP · Purchase
Acquired
Common Stock5400.00.93
2026-08-13
2026-08-13
Altman PeterP · Purchase
Acquired
Common Stock1900.00.92
2026-07-29
2026-07-29
Altman PeterP · Purchase
Acquired
Common Stock5000.00.78
2026-07-17
2026-07-20
Altman PeterP · Purchase
Acquired
Common Stock500.00.83
2026-07-15
2026-07-15
Altman PeterP · Purchase
Acquired
Common Stock1500.00.86
2026-07-14
2026-07-15
Altman PeterP · Purchase
Acquired
Common Stock2800.00.88
2026-07-10
2026-07-10
Altman PeterP · Purchase
Acquired
Common Stock1000.00.94
2026-07-09
2026-07-10
Altman PeterP · Purchase
Acquired
Common Stock1000.00.9
2026-07-08
2026-07-10
Altman PeterP · Purchase
Acquired
Common Stock5500.00.97
2026-07-08
2026-07-08
Altman PeterP · Purchase
Acquired
Common Stock5400.00.96
2026-07-06
2026-07-07
STERTZER SIMON HA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
8000.00.0
2026-07-06
2026-07-07
Altman PeterA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
57688.00.0
2026-07-06
2026-07-07
McClung DavidA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
41501.00.0
2026-07-06
2026-07-07
GILLIS EDWARD MA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
29442.00.0
2026-07-06
2026-07-07
Blank Andrew ScottA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
8000.00.0
2026-07-06
2026-07-07
Slosman MarvinA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
8000.00.0
2026-07-06
2026-07-07
Allen Jim L.A · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
8000.00.0
2026-07-06
2026-07-07
MOYES JAY MA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
8000.00.0
2026-07-06
2026-07-07
Facteau BillA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
8000.00.0
2026-07-02
2026-07-07
Altman PeterF · Tax / exercise payment
Disposed
Common Stock54606.01.24
2026-07-02
2026-07-07
McClung DavidF · Tax / exercise payment
Disposed
Common Stock23125.01.24
2026-07-02
2026-07-07
GILLIS EDWARD MF · Tax / exercise payment
Disposed
Common Stock17269.01.24
2026-06-29
2026-07-01
Altman PeterA · Grant / award
Acquired
Common Stock110625.01.2
2026-06-29
2026-07-01
McClung DavidA · Grant / award
Acquired
Common Stock60483.01.2
2026-06-29
2026-07-01
GILLIS EDWARD MA · Grant / award
Acquired
Common Stock39521.01.2

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000925741BioCardia, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • Tiger X Medical, Inc. · former SEC name · 2011-02-25 to 2016-10-17
  • Cardo Medical, Inc. · former SEC name · 2008-10-29 to 2011-05-25
  • CLICKNSETTLE COM INC · former SEC name · 2000-11-07 to 2008-10-20
  • NAM CORP · former SEC name · 1996-12-23 to 2000-03-29

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$58.0K$62.3K
2023-12-31$477.0K$527.4K
2022-12-31$1.35M$1.56M
2021-12-31$1.01M$1.26M
2020-12-31$145.0K$188.8K
2019-12-31$710.0K$935.7K
2018-12-31$625.0K$838.6K
2017-12-31$479.0K$658.4K

Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

Explore the CPI history ↗